Skip to content
Screener

Axcelis Technologies ACLS Business Segments — Research And Development Expense

Similar metrics at other companies

Alumis Inc. logo
ALMSSingle Reportable — Research And Development Expense
$81.54M-15.6%
Napco Security Technologies logo
NSSCSingle Reportable — Research And Development Expense
$400K+22.0%
Capricor Therapeutics logo
CAPRSingle Reportable — Research And Development Expense
$27.38M+44.7%
Plug Power logo
PLUGSingle Reportable — Research And Development Expense
$12.11M-30.2%
Dogwood Therapeutics logo
DWTXSingle Reportable — Research And Development Expense
$2.67M+9.6%
908 Devices logo
MASSSingle Reportable — Research And Development Expense
$3.47M-9.3%

Other financials

Income statement

See full
Revenue$215.2M+10.6%
Gross profit$91.2M+4.4%
Operating income$20.3M-30.0%
Net income$23.3M-25.8%
EPS (diluted)$0.75-23.5%

Balance sheet

See full
Cash & equivalents$155.0M-10.7%
Total debt$71.5M-2.5%
Total equity$1.1B+4.2%
Total assets$1.4B+4.8%

Cash flow

See full
Operating cash flow$18.4M-53.8%
CapEx$3.6M+79.0%
Free cash flow$14.8M-60.7%

Valuation

See full
Market cap$4.2B+76.5%
Enterprise value$4.12B+80.7%
P/E45.3×+30.3×
P/S4.9×+2.2×

Profitability

See full
Gross margin43%-1.9pp
Operating margin10.3%-7.5pp
Net margin10.7%-7.0pp
FCF margin8.6%-5.1pp

Returns & leverage

See full
Return on equity8.9%-7.3pp
Debt / equity0.1×0.0×
Current ratio4.9×-1.1×

Where this comes from

Reported directly by Axcelis Technologies in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.

The source filing: Axcelis Technologies’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 4:10 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001104659-26-091999
Line itemThree months ended June 30, 2026Three months ended June 30, 2025Six months ended June 30, 2026Six months ended June 30, 2025
Revenue:$215,175$194,544$414,131$387,107
Less:
Cost of revenue123,986107,201242,361210,996
Research and development28,97727,06457,49354,192
Sales and marketing19,55415,00336,90830,127
General and administrative22,37716,31149,13833,668
Total other income5,0676,0327,7429,957
Income tax provision2,0573,6213,4688,126

Item 1. Financial Statements (Unaudited)

FAQ

What is Axcelis Technologies's business segments — research and development expense?
Axcelis Technologies (ACLS) reported business segments — research and development expense of $28.98M in Q2 2026.
How has Axcelis Technologies's business segments — research and development expense changed year-over-year?
Axcelis Technologies's business segments — research and development expense increased by 7.1% year-over-year, from $27.06M to $28.98M.
What is the long-term trend for Axcelis Technologies's business segments — research and development expense?
Over 3 years (2022 to 2025), Axcelis Technologies's business segments — research and development expense has grown at a 11.6% compound annual growth rate (CAGR), from $78.36M to $108.96M.
What does business segments — research and development expense mean?
This metric captures the expenditures dedicated to the innovation, design, and improvement of ion implantation systems and related processing technologies. It reflects the company's commitment to maintaining a competitive edge in the semiconductor equipment market through continuous product development.

Ask your AI about Axcelis Technologies's business segments — research and development expense.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude